Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ARCT Arcturus Therapeutics

13.050
-0.570-4.19%
Close 09/26 16:00 ET
13.0500.0000.00%
Post Mkt Price 09/26 16:30 ET
High
14.560
Open
13.420
Turnover
5.49M
Low
13.020
Pre Close
13.620
Volume
404.01K
Market Cap
346.82M
P/E(TTM)
Loss
52wk High
48.750
Shares
26.58M
P/E(Static)
Loss
52wk Low
11.700
Float Cap
295.35M
Bid/Ask %
-81.82%
Historical High
129.710
Shs Float
22.63M
Volume Ratio
0.95
Historical Low
4.110
Dividend TTM
--
Div Yield TTM
--
P/B
2.03
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
1.79%
Amplitude
11.31%
Avg Price
13.589
Lot Size
1
Float Cap
295.35M
Bid/Ask %
-81.82%
Historical High
129.710
Shs Float
22.63M
Volume Ratio
0.95
Historical Low
4.110
Dividend TTM
--
P/B
2.03
Dividend LFY
--
Turnover Ratio
1.79%
Amplitude
11.31%
Avg Price
13.589
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Arcturus Therapeutics Holdings, Inc. develops pharmaceuticals. It is a clinical-stage mRNA medicines and vaccines company, which focuses on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. The firm's products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
CEO: Mr. Joseph E. Payne
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...